Accuracy of Transient Elastography Data Combined With APRI in Detection and Staging of Liver Disease in Pediatric Patients With Cystic Fibrosis
- 1 November 2019
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 17 (12) , 2561-2569.e5
Abstract
No abstract availableKeywords
Funding Information
- Australian Liver Foundation
- National Health and Medical Research Council (APP1048740, APP1061332)
This publication has 26 references indexed in Scilit:
- Aspartate aminotransferase to platelet ratio and fibrosis‐4 as biomarkers in biopsy‐validated pediatric cystic fibrosis liver diseaseHepatology, 2015
- Utility of transient elastography in the non‐invasive evaluation of cystic fibrosis liver diseaseLiver International, 2013
- Non-Invasive Evaluation of Cystic Fibrosis Related Liver Disease in Adults with ARFI, Transient Elastography and Different Fibrosis ScoresPLOS ONE, 2012
- Liver disease in cystic fibrosisCurrent Opinion in Pulmonary Medicine, 2011
- Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver diseaseJournal of Cystic Fibrosis, 2011
- Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsyHepatology, 2010
- Transient elastography in patients with cystic fibrosisPediatric Radiology, 2010
- Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver diseaseJournal of Cystic Fibrosis, 2009
- Comparison of ultrasound and biopsy findings in children with cystic fibrosis related liver diseaseJournal of Cystic Fibrosis, 2008
- Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosisHepatology, 2004